The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro

J Nutr. 2000 Jan;130(1):15-20. doi: 10.1093/jn/130.1.15.

Abstract

Sambucus nigra (elder) has been documented as a traditional treatment of diabetes. In the present study, an aqueous extract of elder (AEE, 1 g/L) significantly increased 2-deoxy-glucose transport, glucose oxidation and glycogenesis of mouse abdominal muscle in the absence of added insulin (2 x 2 factorial design). in acute 20-min tests, 0.25-1 g/L AEE evoked a stepwise stimulation of insulin secretion from clonal pancreatic beta-cells. The insulin releasing effect of AEE (0.5 g/L) was significantly potentiated by 16.7 mmol/L of glucose and significantly reduced by 0.5 mmol/L of diazoxide. AEE did not further enhance insulin secretion in cells stimulated by 10 mmol/L of L-alanine, 1 mmol/L of 3-isobutyl-1-methylxanthine or a depolarizing concentration of KCl (25 mmol/L). Prior exposure of clonal pancreatic beta-cells to AEE did not alter subsequent stimulation of insulin secretion induced by 10 mmol/L of L-alanine, thereby precluding a detrimental effect on cell viability. The insulinotropic action of AEE was partially dependent upon use of heat during extract preparation. Activity of AEE was heat-stable, acetone-insoluble and unaltered by prolonged exposure to acid/alkali (0.1 mol/L of HCl and NaOH). However, activity was significantly decreased 41% by dialysis to remove components with molecular mass <2000 Da. Sequential extraction with solvents revealed activity in both methanol and water fractions, indicating a cumulative effect of more than one extract constituent. Known constituents of elder, including lectin, rutin and the lipophilic triterpenoid (lupeol) and sterol (beta-sitosterol), did not stimulate insulin secretion. The results demonstrate the presence of insulin-releasing and insulin-like activity in the traditional antidiabetic plant, Sambucus nigra.

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Alanine / pharmacology
  • Animals
  • Diabetes Mellitus, Experimental / drug therapy*
  • Gluconeogenesis / drug effects*
  • Glucose / metabolism*
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / drug effects*
  • Islets of Langerhans / metabolism
  • Male
  • Mice
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / metabolism
  • N-Glycosyl Hydrolases*
  • Phosphodiesterase Inhibitors / pharmacology
  • Plant Proteins / therapeutic use*
  • Protein Synthesis Inhibitors / therapeutic use*
  • Rats
  • Ribosome Inactivating Proteins, Type 2
  • Streptozocin

Substances

  • Insulin
  • Phosphodiesterase Inhibitors
  • Plant Proteins
  • Protein Synthesis Inhibitors
  • Ribosome Inactivating Proteins, Type 2
  • Streptozocin
  • N-Glycosyl Hydrolases
  • Glucose
  • Alanine
  • 1-Methyl-3-isobutylxanthine